LUCID-MS: Patented new chemical entity (NCE)
Lucid-MS is a patented neuroprotective compound that has demonstrated in preclinical models to prevent and reverse myelin degradation, a cause for Multiple Sclerosis, as well as other neurodegenerative diseases and conditions.
Lucid-MS has shown excellent results in several animal models.
LUCID-MS: Disease Modifying Enabling Remyelination
A sampling of the novel qualities of Lucid-MS include:
- Excellent efficacy in various preclinical animal models
- Accelerates functional recovery of mouse models of Multiple Sclerosis, preserves myelin, and reduces zonal degradation
- Does not suppress immune system (non-immunomodulatory)
- Potential oral administration with easy dosing regimen
FSD Pharma has completed the dosing of healthy human volunteers for phase-1 clinical trials for Lucid-MS.
Today there is no cure for Multiple Sclerosis.
FSD Pharma ("HUGE") is trying to change this for millions of people.
Read more about the company here.
-----
(Nasdaq: HUGE): 5 Potential Breakout Catalysts To Focus On Immediately
#1. One Analyst Target Points To A Wild Amount Of Upside Potential (Like Wow)!
In fact, from Thursday's opening valuation, a Goldman Small Cap Research report provides a $4.60 target implying a potential upside of over 5,000%!
Here's some report highlights:
- The two lead product candidates in HUGE's two business lines, which represent unmet needs, are poised to achieve substantial growth and market penetration. HUGE will commence commercialization in early 2024 in one business line and launch a 2H24 Phase II clinical trial in the other.
- Our 12-month price target of $4.60 is based on the future value of the UNBUZZD™ business, and a NPV estimate of the Lucid-MS product. These forecasts are based on projected sales of UNBUZZD™ and Lucid-MS.
-----
#2. A "Pivotal Moment" On unbuzzd's™ Journey Ahead Of Expected Launch.
FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzd(TM)
TORONTO, ON / ACCESSWIRE / May 16, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu"), its new packaging and logo of unbuzzd™ expected to launch this summer, an innovative beverage product that is scientifically formulated from a proprietary blend of vitamins, minerals and botanical extracts designed to support the body's natural processes for metabolizing alcohol and promoting alertness.
On May 16, 2024, Celly Nu and SIX+ONE unveil new packaging and logo for unbuzzd™ expected to launch this summer:
Toronto, Ontario, May 16, 2024 - Celly Nutrition Corp, makers of unbuzzd™, a pioneering beverage company for innovative, cutting-edge alcohol metabolizing technology for recreational use products, is thrilled to announce the launch of its newly designed packaging and logo, meticulously crafted in collaboration with the renowned branding agency, Six+One. This launch signifies a pivotal moment in unbuzzd's journey in preparation for the expected launch this summer.
The newly introduced packaging and logo blend a playful, energetic, and unexpected aesthetic with a fresh, upscale finish. This combination not only reflects a premium and distinct look but also captures unbuzzd's unique personality, resonating with a diverse audience ranging from college students to working professionals, and even those golfers who are mindful of family commitments.The design features a vibrant green and yellow color scheme that hints at the beverage's "clear-eyed citrus" flavor, appealing to a broad demographic of drinkers. The fluid and fun logo is designed to connect with consumers on a deeper level, striking a refreshing balance between enjoyment and responsibility.
John Duffy, CEO of Celly Nutrition, expressed his excitement about the new branding, stating, "At unbuzzd, we view branding as a crucial element in connecting with our consumers. It goes beyond visual identity; it's about making a meaningful impact. Our design encapsulates this philosophy by merging fun with sophistication, proving that serious products can be both enjoyable and engaging."
...
Read the full article here.
-----
#3. An Exclusive Option Agreement With The University Of Southern California Highlights Potential To Increase Target Markets.
FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business Applications
TORONTO, ON / ACCESSWIRE / June 13, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), ..., today announces that it entered into an exclusive option agreement with the University of Southern California (USC) to evaluate dietary supplement technology for commercialization. The option agreement, signed June 11, 2024, allows FSD Pharma to exclusively evaluate the novel technology for a 6-month term. At the end of this term, FSD Pharma will have the option to either extend it for an additional 6 months or to sign an exclusive license for the technology with USC. This novel technology is being evaluated for the potential to further increase the effectiveness of certain ingredients currently present in unbuzzd™. ...
"This partnership with FSD Pharma underscores USC's longstanding commitment to fostering innovation and translating scientific research into practical solutions that benefit society," said Dr. Erin Overstreet, executive director at the USC Stevens Center for Innovation. "We are excited to be working with FSD Pharma, leveraging their expertise in the biopharmaceutical industry, exploring the potential of this novel technology, and enhancing the portfolio of dietary supplement products. Together, we aim to bring forward new advancements that contribute to positive health and well-being for all."
"We are thrilled to sign the option agreement with USC. We are looking forward to evaluating this novel technology that has the potential to both further enhance the effectiveness of unbuzzd™ and increase our target markets by enabling the development of new products," said Zeeshan Saeed, Founder, CEO and Executive Co-Chairman at FSD Pharma.
Read the full article here.
-----
#4. Oversold Technicals May Signal The Coming Of A Mega-Bounce/Healthy Reversal.
Here's what was cooking at 12:00PM EST Thursday. Barchart was reporting multiple oversold technical indicators for HUGE.
These technicals could be signaling a healthy reversal is approaching in the near term.
Here's the definition of a "reversal" from Investopedia:
"A reversal is a change in the price direction of an asset. A reversal can occur to the upside or downside. Following an uptrend, a reversal would be to the downside. Following a downtrend, a reversal would be to the upside. Reversals are based on overall price direction and are not typically based on one or two periods/bars on a chart."
Here's the technicals to pay close attention to (as of 12:00PM EST Thursday):
- 9-Day Relative Strength Index: 21.28%
- 14-Day Relative Strength Index: 23.61%
When these numbers drop down to the 30% range and lower, they can be viewed as being in oversold territory. While in this territory, they can paint the picture of a profile that is undervalued.
- 14-Day Raw Stochastic: 7.01%
- 14-Day Williams %R: 92.99%
As the Raw Stochastic nears the 10% range and lower and the Williams %R nears the 90% range or higher, these technical indicators may also be viewed as oversold and undervalued.
Keep an eye on these technicals closely.
-----
#5. A Low(ish) Float Could Create A Volatile, Must-Watch Scenario In A Blink.
According to the Yahoo Finance website, HUGE has a somewhat low(ish) float.
The website reports this profile to have approximately 38.08Mn shares in its float.
Why is that important? It's important on one crucial level. Volatility.
Could more positive company news midway through 2024 provide a near term spark?
-----
HUGE Recap - 5 Potential Breakout Catalysts To Know
#1. One Analyst Target Points To A Wild Amount Of Upside Potential (Like Wow)!
#2. A "Pivotal Moment" On unbuzzd's™ Journey Ahead Of Expected Launch.
#3. An Exclusive Option Agreement With The University Of Southern California Highlights Potential To Increase Target Markets.
#4. Oversold Technicals May Signal The Coming Of A Mega-Bounce/Healthy Reversal.
#5. A Low(ish) Float Could Create A Volatile, Must-Watch Scenario In A Blink.
-----
Coverage is officially initiated on (Nasdaq: HUGE). Get it on your radar now!
Sincerely,
Kai Parker
StockWireNews
(Always Remember The St-ock Prices Could Be Significantly Lower Now From The Dates I Provided.)
Post a Comment
Post a Comment